January 29, 2025 - 11:22

Sonnet BioTherapeutics has successfully obtained a patent from the European Patent Office (EPO) for its groundbreaking fully human albumin binding (FHAB) technology. This significant achievement underscores the company’s commitment to advancing therapeutic solutions that leverage the unique properties of human albumin.
The FHAB technology is designed to enhance the delivery and efficacy of various therapeutic agents, potentially transforming treatment options for patients with a range of medical conditions. By utilizing human albumin, Sonnet aims to improve the pharmacokinetics and bioavailability of drugs, thereby optimizing therapeutic outcomes.
This patent not only strengthens Sonnet's intellectual property portfolio but also positions the company as a leader in the biotherapeutics space. With the growing demand for innovative treatment modalities, the successful patent acquisition is expected to facilitate further research and development initiatives. The company is poised to explore new partnerships and collaborations to maximize the potential of its FHAB technology in the healthcare market.
May 5, 2026 - 07:23
STC students build custom picnic tables to enhance Technology Campus lookStudents from the South Texas College Student Government Association at the Technology Campus recently completed a hands-on project to improve their school`s outdoor spaces. They built and...
May 4, 2026 - 21:41
Western states are installing AI cameras to detect wildfires earlyA growing number of western states are turning to artificial intelligence to catch wildfires in their earliest moments. The technology, developed by companies like Pano AI, uses high-resolution...
May 4, 2026 - 00:21
Will Houston SMR Operations Center Bring NuScale Power's (SMR) Technology Closer to Core Energy Customers?NuScale Power Corporation has opened a new Operations Center in Houston`s CityCentre, putting its small modular reactor operations right in the middle of a major energy hub. The move places the...
May 3, 2026 - 03:30
NVIDIA (NVDA): Among the Best American Stocks to Buy in the Technology SectorNVIDIA Corporation (NASDAQ:NVDA) has been identified as one of the top 10 American technology stocks to buy right now. The company is seeing a massive surge in demand for its high-end AI computing...